Your browser doesn't support javascript.
loading
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly.
van Altena, Richard; Akkerman, Onno W; Alffenaar, Jan-Willem C; Kerstjens, Huib A M; Magis-Escurra, Cecile; Boeree, Martin J; van Soolingen, Dick; de Lange, Wiel C M; Bolhuis, Mathieu S; Hoefsloot, Wouter; de Vries, Gerard; van der Werf, Tjip S.
Affiliation
  • van Altena R; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Alffenaar JC; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Kerstjens HA; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Magis-Escurra C; Tuberculosis Center, University Center for Chronic Diseases Dekkerswald, Radboud Nijmegen University Medical Center, Nijmegen, The Netherlands.
  • Boeree MJ; Tuberculosis Center, University Center for Chronic Diseases Dekkerswald, Radboud Nijmegen University Medical Center, Nijmegen, The Netherlands.
  • van Soolingen D; Tuberculosis Reference Laboratory, Centre for Infectious Diseases, National Institute for Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • de Lange WC; Depts of Medical Microbiology and Lung Disease, Radboud Nijmegen University Medical Center, Nijmegen, The Netherlands.
  • Bolhuis MS; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Hoefsloot W; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • de Vries G; Tuberculosis Center, University Center for Chronic Diseases Dekkerswald, Radboud Nijmegen University Medical Center, Nijmegen, The Netherlands.
  • van der Werf TS; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
Eur Respir J ; 48(6): 1800-1802, 2016 12.
Article in En | MEDLINE | ID: mdl-27824604
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Guideline / Observational_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Guideline / Observational_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom